JNK and p38 stresskinases - Degenerative effectors of signal- transduction-cascades in the nervous system

Progress in Neurobiology

Volumn 61, Issue 1, 2000, Pages 45-60

  Mielke, Kirsten ^a   Herdegen, Thomas ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN BCL 2; PROTEIN C JUN; PROTEIN P53; STEROID RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TAU PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BRAIN ISCHEMIA; CYTOPLASM; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NERVE LESION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRESS;

ANIMALS; APOPTOSIS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASES; NERVOUS SYSTEM; NERVOUS SYSTEM PHYSIOLOGY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 0033970158     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(99)00042-8     Document Type: Review

References (145)

1. Adler V., Yin Z., Fuchs S.Y., Benezera M., Rosario L., Tew K.D., Pincus M.R., Sardana M., Herderson C.J., Wolf C.R., Davis R.J., Ronai Z. Regulation of JNK signaling by GSTp. EMBO J. 18:1999;1321-1334.
2. Arias J., Alberts A.S., Brindle P., et al. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature. 370:1994;226-229.
3. Aloyz R.S., Bamji S.X., Pozniak C.D., Toma J.G., Atwal J., Kaplan D.R., Miller F.D. p53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors. J. Cell. Biol. 143:1998;1691-1703.
4. Badger A.M., Bradbeer J.N., Votta B., Lee J.L., Adams J.L., Griswold D.E. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J. Pharmacol. Exp. Ther. 279:1996;1453-1461.
5. Becher B., Barker P.A., Owens T., Antel J.P. CD95-CD95L: can the brain learn from the immune system? Trends in Neuroscience. 21:1998;114-117.
6. Becker A.J., Gillardon F., Blumcke I., Langendorfer D., Beck H., Wiestler O.D. Differential regulation of apoptosis-related genes in resistant and vulnerable subfields of the rat epileptic hippocampus. Brain Res. Mol. Brain Res. 67:1999;172-176.
7. Behrens A., Sibilia M., Wagner E.F. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nature Gent. 21:1999;326-329.
8. Brecht S., Simler S., Vergnes M., Mielke K., Marescaux C., Herdegen T. Repetitive electroconvulsive seizures induce activity of c-Jun N-terminal kinase and compartment specific desensitization of c-Jun phosphorylation in the rat brain. Brain Res. Mol. Brain Res. 68:1999;101-108.
9. Bruce A.J., Boling W., Kindy M.S., et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med. 2:1996;788-794.
10. Butterfield L., Zentrich E., Beekman A., Heasley L.E. Stress- and cell type-dependent regulation of transfected c-Jun N-terminal kinase and mitogen-activated protein kinase kinase isoforms. Biochem. J. 338:1999;681-686.
11. Camps M., Chabert C., Muda M., Boschert U., Gilliereon C., Arkinstall S. Induction of the mitogen-activated protein kinase phosphatase MKP3 by nerve growth factor in differentiating PC12. FEBS Lett. 425:1998;271-276.
12. Carboni L., Tacconi S., Carletti R., Bettini E., Ferraguti F. Localization of the messenger RNA for the c-Jun NH2-terminal kinase kinase in the adult and developing rat brain: an in situ hybridization study. Neuroscience. 80:1997;147-160.
13. Carboni L., Carletti R., Tacconi S., Corti C., Ferraguti F. Differential expression of SAPK isoforms in the rat brain. An in situ hybridisation study in the adult rat brain and during post-natal development. Mol. Brain Res. 60:1998;57-68.
14. Carletti R., Tacconi S., Bettini E., Ferraguti F. Stress activated protein kinases, a novel family of mitogen-activated protein kinases, are heterogeneously expressed in the adult rat brain and differentially distributed from extracellular-signal-regulated protein kinases. Neuroscience. 69:1995;1103-1110.
15. Cavigelli M., Dolfi F., Claret F.X., Karin M. Induction of c-fos expression through JNK-mediated TCF-ELK1 phosphorylation. EMBO J. 14:1995;5957-5964.
16. Chihab R., Ferry C., Koziel V., Monin P., Daval J.L. Sequential activation of activator protein-1-related transcription factors and JNK protein kinases may contribute to apoptotic death induced by transient hypoxia in developing brain neurons. Brain Res. Mol. Brain Res. 63:1998;105-120.
17. Chu Y., Solski P.A., Khosravi-Far R., Der C.J., Kelly K. The mitogen-activated protein kinase phosphatases PAC1, MKP1, and MKP2 have unique substrate specifities and reduced activity in vivo towards the ERK2 sevenmarker mutation. J. Biol. Chem. 271:1996;6497-6501.
18. Cruzalegui F.H., Hardingham G.E., Bading H. c-Jun functions as a calcium-regulated transcriptional activator in the absence of JNK/SAPK1 activation. EMBO J. 18:1999;1335-1344.
19. Cuenda A., Cohen P., Buee-Scherrer V., Goedert M. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stress is mediated via SAPKK3 (MKK6); comparision of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J. 16:1997;295-305.
20. Dechant G., Barde Y.A. Signalling through the neurotrophin receptor p75NTR. Current Biology. 7:1997;413-418.
21. Derijard B., Raingeaud J., Barrett T., Wu I.H., Han J., Ulevitch R.J., Davis R.J. Independent human MAP kinase signaltransduction pathway defined by MEK and MKK isoforms. Science. 267:1995;682-685.
22. Dickens M., Rogers J.S., Cavanagh J., Raitano A., Xia Z., Halpern J.R., Greenberg M.E., Sawyers C.L., Davis R.J. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science. 277:1997;693-696.
23. Eilers A., Whitfield J., Babij C., Rubin L.L., Ham J. Role of the Jun kinase pathway in the regulation of c-Jun expression and apoptosis in sympathetic neurons. J. Neurosci. 18:1998;1713-1724.
24. Enslen H., Raingeaud J., Davis R.J. Selective activation of p38 mitogen-activeted protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem. 273:1998;1741-1748.
25. Estus S., Zaks W.J., Freeman R.S., Gruda M., Bravo R., Johnson E.M. Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J. Cell. Biol. 127:1994;1717-1727.
26. Ferrer I., Planas A.M., Pozas E. Radiation-induced apoptosis in developing rats and kainic acid-induced excitotoxicity in adult rats are associated with distinctive morphological and biochemical c-Jun/AP-1 (N) expression. Neuroscience. 80:1997;449-458.
27. Foltz I.N., Gerl R.E., Wieler J.S., Luckach M., Salmon R.A., Schrader J.W. Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly conserved c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activated by environmental stresses and physiological stimuli. J. Biol. Chem. 273:1998;9344-9351.
28. Freshney N.W., Rawlinson L., Guesdon F., Jones E. Interleukin-1 activates a novel protein kinase cascade which results in the phosphorylation of hsp27. Cell. 78:1994;1039-1049.
29. Fuchs S.Y., Adler V., Pincus M.R., Ronai Z. MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. USA. 95:1998;10541-10546.
30. Gass P., Herdegen T. Expression of AP-1 proteins in excitotoxic-neurodegenerative disorders and following nerve fiber injury. Prog. Neurobiol. 47:1995;257-290.
31. Giasson B.I., Mushynski W.E. Study of proline-directed protein kinases involved in phosphorylation of the heavy neurofilament subunit. J. Neurosci. 17:1997;9466-9472.
32. Goedert M., Cuenda A., Craxton M., Jakes R., Cohen P. Activation of the novel MAP kinase homologue SAPK4 by cytokines and cellular stress is mediated by SKK3 (MKK6); comparision of its substrate specificity with that of other SAP kinases. EMBO J. 16:1997;3563-3571.
33. Gupta S., Campbell D., Derijard B., Davis R.J. Transcription factor ATF-2 regulation by the JNK signal transduction pathway. Science. 267:1995;389-393.
34. Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K., Derijard B., Davis R.J. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15:1996;2760-2770.
35. Guyton K.Z., Liu Y., Gorospe M., Xu Q., Holbrook N.J. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J. Biol. Chem. 271:1996;4138-4142.
36. Han T.H., Prywes R. Regulatory role of MEF2C in serum induction of the c-jun promoter. Mol. Cell. Biol. 15:1995;2907-2915.
37. Han J., Jiang Y., Li Z., Kravchenko V.V., Ulevitch R.J. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature. 386:1997;296-299.
38. Hannun Y.A. Functions of ceramide in coordinating cellular responses to stress. Science. 274:1996;1855-1859.
39. Hartfield P.J., Bilney A.J., Murray A.W. The role of c-Jun N-terminal kinase activation in ceramide-induced apoptosis in PC12 cells. Biochem. Soc. Trans. 26:1998;S327.
40. Hartfield P.J., Bilney A.J., Murray A.W. Neurotrophic factors prevent ceramide-induced apoptosis downstream of c-Jun N-terminal kinase activation in PC12 cells. J. Neurochem. 71:1998;161-169.
41. Hazzalin C.A., Cano E., Cuenda A., Barratt M.J., Cohen P., Mahadevan L.C. P38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficient. Curr. Biol. 6:1996;1028-1031.
42. Heidenreich K.A., Kummer J.L. Inhibition of p38 mitogen-activated protein kinase by insulin in cultured fetal neurons. J. Biol. Chem. 271:1996;9891-9894.
43. Henry J.R., Rupert K.C., Dodd J.H., Turchi I.J., Wadsworth S.A., Cavender D.E., Fahmy B., Olini G.C., Davis J.E., Pellegrino-Gensey J.L., Schafer P.H., Siekierka J.J. 6-Amino-2-(4-fluorophenyl)-4-methoxy-3-(4-pyridyl)1H-pyrrolo[2,3-b]pyridine (RWJ 68354): A potent and selective p38 kinase inhibitor. J. Med. Chem. 41:1998;4196-4198.
44. Herdegen T. Jun, Fos, and CREB/ATF transcription factors in the brain: control of gene expression under normal and pathophysiological conditions. Neuroscientist. 2:1996;153-161.
45. Herdegen T., Skene P., Bähr M. The c-Jun protein - transcriptional mediator of neuronal survival, regeneration and death. Trends Neurosci. 20:1997;227-231.
46. Herdegen T., Leah J.D. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Reviews. 28:1998;370-490.
47. Herdegen T., Claret F.X., Kallunki T., Martin-Villalba A., Winter C., Hunter T., Karin M. Lasting N-terminal phosphorylation of c-Jun and activation of JNK/SAPK kinases neuronal injury. J. Neurosci. 18:1998;5124-5135.
48. Herzog K.H., Chen S.C., Morgan J.I. c-jun is dispensible for developmental cell death and axogenesis in the retina. J. Neurosci. 19:1999;4349-4359.
49. Hirsch D.D., Stork P.J.S. Mitogen-activated protein kinase phosphatases inactivate stress-activated protein kinase pathways in vivo. J. Biol. Chem. 272:1997;4568-4575.
50. Horstmann S., Kahle P.J., Borasio G.D. Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro. J. Neurosci. Res. 15:1998;483-490.
51. Houle, J., Schramm, P., Herdegen, T., 1999. Trophic factor modulation of c-Jun expression in supraspinal neurons after chronic spinal cord injury. Exp Neurol, in press.
52. Hsieh T., Simler S., Vergnes M., Gass P., Maresceaux C., Wigand S., Zimmermann M., Herdegen T. BDNF restores the re-expression of Jun and Fos inducible transcription factors in the rat brain following repetitive electroconvulsive seizures. Exp. Neurol. 149:1998;161-174.
53. Huang S., Jiang Y., Li Z., Nishida E., Methias P., Lin S., Ulevitch J.R., Nemerow G.R., Han J. Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity. 6:1997;739-749.
54. Ip Y.T., Davis R.J. Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Curr. Opin. Cell. Biol. 10:1998;205-219.
55. Jiang Y., Chen C., Li Z., Guo W., Gegner J.A., Lin S., Han J. Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J. Biol. Chem. 271:1996;17,920-17,926.
56. Juo P., Kuo C.J., Reynolds S.E., Konz R.F., Raingeaud J., Davis R.J., Biemann H.P., Blenis J. Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Mol. Cell. Biol. 17:1997;24-35.
57. Kallunki T., Su B., Tsigelny I., et al. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes and Development. 8:1994;2996-3007.
58. Kallunki T., Deng T., Hibi M., Karin M. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell. 87:1996;1-20.
59. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:1995;16,483-16,486.
60. Kenney A.M., Kocsis J.D. Peripheral axotomy induces long-term c-Jun amino-terminal kinase-1 activation and activator protein-1 binding activity by c-Jun and junD in adult rat dorsal root ganglia in vivo. J. Neurosci. 18:1998;1318-1328.
61. Kim I.J., Lee K.W., Park B.Y., Lee J.K., Park J., Choi I.Y., et al. Molecular cloning of multiple splicing variants of JIP-1 preferentially expressed in brain. J. Neurochem. 72:1999;1335-1343.
62. Ko H.W., Park K.Y., Kim H., Han P.L., Kim Y.U., Gwag B.J., Choi E.J. Ca2±mediated activation of c-Jun N-terminal kinase and nuclear factor kappa B by NMDA in cortical cell cultures. J. Neurochem. 71:1998;1390-1395.
63. Kuan C.Y., Yang D.D., Roy D.R.S., Davis R.J., Rakic P., Flavell R.A. The JNK1 and JNK2 protein kinases regulate regional-specific apoptosis during early brain development. Neuron. 22:1999;667-676.
64. Kummer J.L., Rao P.K., Heidenreich K.A. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 272:1997;20,490-20,494.
65. Kyriakis J.M., Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271:1996;24,313-24,316.
66. Lallemand D., Ham J., Garbay S., Bakiri L., Traincard F., Jeannequin O., Pfarr C.M., Yaniv M. Stress-activated protein kinases are negatively regulated by cell density. EMBO J. 17:1998;5615-5626.
67. Lavoie J.N., Lambert H., Hickey E., Weber L.A., Landry J. Modulation of cellular thermoresistence and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27. Mol. Cell. Biol. 15:1995;505-516.
68. Lechner C., Zahalka M.A., Giot J.F., Moller N.P., Ullrich A. ERK6, a mitogen-activates protein kinase involved in C2C12 myoblast differentiation. Proc. Natl. Acad. Sci. USA. 93:1996;4355-4359.
69. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulthy D., Blumenthal M.J., Heys J.R., Landvatter S.V., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 372:1994;739-746.
70. Lee F.S., Hagler J., Chen Z.J., Maniatis T. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell. 88:1997;213-222.
71. Lin A., Minden A., Martinetto H., Claret F.X., Lange-Carter C., Mercurio F., Johnson G.L., Karin M. Identification of a dual specificity kinase that activates the Jun kinase and p38-Mpk2. Science. 268:1995;289-290.
72. Liu Y.F. Expression of polyglutamine-expanded Huntingtin activates the SEK1-JNK pathway and induces apoptosis in a hippocampal neuronal cell line. J. Biol. Chem. 273:1998;28,873-28,877.
73. Liu Y., Gorospe M., Yang C., Holbrook N.J. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1 dependent gene activation. J. Biol. Chem. 270:1995;8377-8380.
74. Luo Y., Umegaki H., Wang X., Abe R., Roth G.S. Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J. Biol. Chem. 273:1998;3756-3764.
75. Maroney A.C., Glicksman M.A., Basma A.N., et al. Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J. Neurosci. 18:1998;104-111.
76. 3F12 SAP kinase. Mol. Brain Res. 35:1996;47-57.
77. Martin-Villalba, A., Herr, I., Jeremias, J., Hahne, M., Brandt, R., Vogel, J., Schenkel, J., Herdegen, T., Debatin, K.M., 1999. CD95-Ligand (Fas-Ligand/APO-1L) and Trail mediate ischemia-induced apoptosis in neurons. J Neuroscience, in press.
78. Matsuyama T., Hata R., Yamamoto Y., Tagaya M., Akita H., Uno H., Wanaka A., Furuyama J., Sugita M. Localization of the Fas antigen mRNA induced in the postischemic murine forebrain by in situ hybridization. Mol. Brain Res. 34:1995;166-172.
79. Maundrell K., Antonsson B., Magnenat E., Camps M., Muda M., Chabert C., Gillieron C., Boschert U., Vial-Knecht E., Martinou J.C., Arkinstall S. Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J. Biol. Chem. 272:1997;25,238-25,242.
80. May G.H.W., Allen K.E., Clark W., Funk M., Gillespie D.A.F. Analysis of the interaction between c-jun and c-Jun N-terminal kinase in vivo. J. Biol. Chem. 273:1998;33,429-33,435.
81. McLaughlin M.M., Kumar S., McDonnell P.C., Van Horn S., Lee J.C., Livi G.P., Young P.R. Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBO p38 MAP kinase. J. Biol. Chem. 271:1996;8488-8492.
82. Meier R., Rouse J., Cuenda A., Nebreda A.R., Cohen P. Cellular stress and cytokines activate multiple mitogen-activated-protein kinase kinase homologues in PC12 and KB cells. Eur. J. Biochem. 236:1996;796-805.
83. Mendelsohn K.G., Contois L.R., Tevosian S.G., Davis R.J., Paulson K.E. Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc. Natl. Acad. Sci. USA. 93:1996;12,908-12,913.
84. Meriin A.B., Gabai V.L., Yaglom J., Shifrin V.L., Sherman M.Y. Proteasome inhibitors activate stress kinases and induce Hsp72. J. Biol. Chem. 273:1998;6373-6379.
85. Meriin A.B., Yaglom J.A., Gabai V.L., Mosser D.D., Zon L., Sherman M.Y. Protein-damaging stresses activate c-Jun N-terminal kinase via inhibition of ist dephosphorylation: a novel pathway controlled by Hsp72. Mol. Cell. Biol. 19:1999;2547-2555.
86. Mielke K., Brecht S., Dorst A., Herdegen T. Activation of JNK and p38 stress kinases, c-Jun phosphorylation and c-Jun/AP-1 DNA binding activity following kainic acid induced seizures. Neuroscience. 91:1999;471-483.
87. Mielke, K., Damm, A., Herdegen, T., 1999b. Selective expression of JNK isoforms and stress-specific JNK activity in neural cell lines. Mol. Brain Res., submitted.
88. Minden A., Karin M. Regulation and function of the JNK subgroup of MAP kinases. Biochem. Biophys. Acta. 1333:1997;F85-F104.
89. Misra-Press A., Rim C.S., Yao H., Robertson M.S., Stork P.J. A novel mitogen-activated protein kinase phosphatase. Structure, expression, and regulation. J. Biol. Chem. 270:1995;14,587-14,596.
90. Miyashita T., Krajewski S., Krajewski M., Wang H.G., Lin H.K., Liebermann D.A., Hoffman B., Reed J.C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1994;1799-1805.
91. Mizukami Y., Yoshioka K., Morimoto S., Yoshida K. A novel mechanism of JNK1 activation. J. Biol. Chem. 272:1997;16,657-16,662.
92. Moriguchi T., Toyoshima F., Masuyama N., Hanafusa H., Gotoh Y., Nishida E. A novel SAPK/JNK kinase, MKK7, stimulated by TNFα and cellular stresses. EMBO J. 16:1997;7045-7053.
93. Natoli G., Costanzo A., Ianni A., Templeton D.J., Woodgett J.R., Balsano C., Levrero M. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science. 275:1997;200-203.
94. Natoli G., Costanzo A., Guido F., Moretti F., Levrero M. Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling. Biochem. Pharmacol. 56:1998;915-920.
95. Nemoto S., Xiang J., Huang S., Lin A. Induction of apoptosis by SB202190 through inhibition of p38β mitogen-activated protein kinase. J. Biol. Chem. 273:1998;16,415-16,420.
96. Ni H., Wang X.S., Diener K., Yao Z. MAPKAPK5, a novel mitogen-activated protein kinase (MAPK)-activated protein kinase, is a substrate of the extracellular-regulated kinase (ERK) and p38 kinase. Biochem. Biophys. Res. Commun. 243:1998;492-496.
97. Nicholson D.W., Thornberry N.A. Caspases: killer proteases. Trends Biol. Sci. 22:1997;299-306.
98. Nuydens R., de Jong M., Van den Kieboom G., Heers C., Dispersyn G., Cornelissen F., Nuydens R., Borgers M., Geerts H. Okadaic acid-induced apoptosis in neuronal cells: evidence for an abortive mitotic attempt. J. Neurochem. 70:1998;1124-1133.
99. Oo T.F., Henchcliffe C., James D., Burke R.E. Expression of c-fos, c-jun, and c-jun N-terminal kinase (JNK) in a developmental model of induced apoptotic death in neurons of the substantia nigra. J. Neurochem. 72:1999;557-564.
100. Park J., Kim I., Oh Y.J., Lee K., Han P.L., Choi E.J. Activation of c-Jun N-terminal kinase antagonizes an anti-apoptotic action of Bcl-2. J. Biol. Chem. 272:1997;16,725-16,728.
101. Pena L.A., Fuks Z., Kolesnick R. Stress-induced apoptosis and the sphingomyelin pathway. Biochem. Pharmacol. 53:1997;615-621.
102. Price M.A., Treisman R. The p38 and ERK MAP kinase pathways cooperate to activate Ternary Complex factors and c-fos transcription in response to UV light. EMBO J. 15:1996;6552-6563.
103. Raingeaud J., Gupta S., Rogers J., Dickens M., Han J., Ulevitch R.J., Davis R.J. Pro-inflammatory cytokines and environmental stress causes p38 MAP kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270:1995;7420-7426.
104. Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., Davis R.J. MKK3- and MKK6- regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16:1996;1247-1255.
105. Reynolds C.H., Nebreda A.R., Gibb G.M., Utton M.A., Anderton B.H. Reactivating kinase/p38 phosphorylates tau protein in vitro. J. Neurochem. 69:1997;191-198.
106. Reynolds C.H., Utton M.A., Gibb G.M., Yates A., Anderton B.H. Stress-activated protein kinase/c-jun [it]N[rm]-terminal kinase phosphorylates tau protein. J. Neurochem. 68:1997;1736-1744.
107. Rincon M., Whitmarsh A., Yang D.D., Weiss L., Derijard B., Jayaraj P., Davis R.J., Flavell R.A. The JNK pathway regulates the in vivo deletion of immature CD4+CD8+thymocytes. J. Exp. Med. 188:1998;1817-1830.
108. Rogatsky I., Logan S.K., Garabedian M.J. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA. 95:1998;2050-2055.
109. Rohan P.J., Davis P., Moskaluk C.A., Kearns M., Krutzsch H., Siebenlist U., Kelly K. PAC-1: a mitogen-induced nuclear protein-tyrosine phosphatase. Science. 259:1993;1763-1769.
110. Rouse J., Cohen P., Trigon S., Morange M., Alonso-Llamzares A., Zamanillo D., Hunt T., Nebreda A.R. A novel kinase cascade triggered by chemical stress and heat shock which stimulates MAP kinase-activated protein kinase-2 and phosphorylation of the small heat shock proteins. Cell. 78:1994;1027-1037.
111. Sabapathy K., Hu Y., Kallunki T., Schreiber M., David J.P., Jochum W., Wagner E.F., Karin M. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr. Biol. 9:1999;116-125.
112. Sadot E., Jaaro H., Seger R., Ginzburg I. Ras-signaling pathways: positive and negative regulation of tau expression in PC12 cells. J. Neurochem. 70:1998;428-431.
113. Sanchez I., Hughes R.T., Mayer B.J., Yee K., Woodgett J.R., Avruch J., Kyriakis J.M., Zon L.I. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature. 372:1994;794-798.
114. Saporito M.S., Brown E.M., Miller M.S., Carswell S. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo. J. Pharmacol. Exp. Ther. 288:1999;421-427.
115. Schlingensiepen K.H., Schlingensiepen R., Kunst M., et al. Opposite functions of Jun-B and c-Jun in growth regulation and neuronal differentiations. Dev. Genetics. 14:1993;305-312.
116. Schreiber M., Kobus A., Piu F., Szabowski A., Mohle-Steinlein U., Tian J., Karin M., Angel P., Wagner E.F. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13:1999;607-619.
117. Shimoke K., Yamagishi S., Yamada M., Ikeuchi T., Hatanaka H. Inhibition of phosphatidylinositol 3-kinase activity elevates c-Jun N-terminal kinase activity in apoptosis of cultured cerebellar granule neurons. Brain Res. Dev. Brain Res. 112:1999;245-253.
118. Shioda S., Ozawa H., Dohi K., Mizushima H., Matsumoto K., Nakajo S., Takaki A., Zhou C.J., Nakai Y., Arimura A. PACAP protects hippocampal neurons against apoptosis: involvement of JNK/SAPK signaling pathway. Ann. NY Acad. Sci. 865:1998;111-117.
119. Sluss H.K., Barrett T., Derijard B., Davis R.J. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol. Cell. Biol. 14:1994;8376-8384.
120. Sluss H.K., Han Z., Barrett T., Davis R.J., Ip Y.T. A JNK signal transduction pathway that mediates morphogenesis and an immune response in Drosophila. Genes Dev. 10:1996;2745-2758.
121. Stokoe D., Caudwell B., Cohen P.T.W., Cohen P. The substrate specificity and structure of mitogen-activated protein (MAP) kinase-activated protein kinase-2. Biochem. J. 296:1992;843-849.
122. Takenaka K., Moriguchi T., Nishida E. Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest. Science. 280:1998;599-602.
123. Tan Y., Rouse J.R., Zhang A., Cariati S., Boccia C., Cohen P., Comb M.J. FGF and stress regulated CREB via a pathway involving the RK/p38 MAP kinase homologue and MAPKAP2. EMBO J. 15:1996;4629-4642.
124. Tournier C., Whitmarsh A.J., Cavanagh J., Barrett T., Davis R.J. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. Proc. Natl. Acad. Sci. USA. 94:1997;7337-7342.
125. van Dam H., Wilhelm D., Herr I., Steffen A., Herrlich P., Angel P. ATF-2 is preferentially activated by stress-activated protein kinase to mediated c-jun induction in response to genotoxic agents. EMBO J. 14:1995;1798-1811.
126. Virdee K., Bannister A.J., Hunt S.P., Tolkovsky A.M. Comparision between the timing of JNK activation, c-Jun phosphorylation, and onset of death commitment in sympathetic neurones. J. Neurochem. 69:1997;550-561.
127. Walton K.M., DiRocco R., Bartlett B.A., Koury E., Marcy V.R., Jarvis B., Schaefer E.M., Bhat R.V. Activation of p38 in microglia after ischemia. J. Neurochem. 70:1998;1764-1767.
128. Wang X., Ron D. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD 153) by p38 MAP kinase. Science. 272:1996;1347-1349.
129. Wang X.S., Diener K., Manthey C.L., Wang S., Rosenzweig B., Bray J., Delaney J., Cole C.N., Chan-Hui P.Y., Mantlo N., Lichenstein H.S., Zukowski M., Yao Z. Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J. Biol. Chem. 272:1997;23,668-23,674.
130. Wang X., Flynn A., Waskiewicz A.J., Webb B.L., Vries R.G., Baines I.A., Cooper J.A., Proud C.G. The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways. J. Biol. Chem. 273:1998;9373-9377.
131. Waskiewicz A.J., Flynn A., Proud C.G., Cooper J.A. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16:1997;1909-1920.
132. Watson A., Eilers A., Lallemand D., Kyriakis J., Rubin L.L., Ham J. Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons. J. Neurosci. 18:1998;751-762.
133. Whitmarsh A.J., Davis R.J. Transcription factor AP-1 regulation by mitogen-activeted protein kinase signal transduction pathways. J. Mol. Med. 74:1996;589-607.
134. Whitmarsh A.J., Cavanagh J., Tournier C., Yasuda C., Davis R.J. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science. 281:1998;1671-1674.
135. Wisdom R., Johnson R.S., Moore C. c-Jun regulates cell cycle progression and apoptosis by distinct mechansims. EMBO J. 18:1999;188-197.
136. Wu Z., Wu J., Jacinto E., Karin M. Molecular cloning and characterization of human JNKK2, a novel Jun NH2-terminal kinase-specific kinase. Mol. Cell. Biol. 17:1997;7407-7416.
137. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
138. Xu X., Raber J., Yang D., Su B., Mucke L. Dynamic regulation of c-Jun N-terminal kinase activity in mouse brain by environmental stimuli. Proc. Natl. Acad. Sci. USA. 94:1997;12,655-12,660.
139. Yang D.D., Kuan C.Y., Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., Rakic P., Flavell R.A. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the JNK 3 gene. Nature. 289:1997;865-870.
140. Yang D., Tournier C., Wysk M., Lu H-T., Xu J., Davis R.J., Flavell R.A. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proc. Natl. Acad. Sci. USA. 94:1997;3004-3009.
141. Yang X., Khosravi-Far R., Chang H.Y., Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell. 89:1997;1067-1076.
142. Zervos A.S., Faccio L., Gatto J.B., Kyriakis J.M., Brent R. Mxi2, a mitogen-activated protein kinase that recognize and phosphorylates Max protein. Proc. Natl. Acad. Sci. USA. 92:1995;10,531-10,534.
143. Zhang Y., Zhou L., Miller C.A. A splicing variant of a death domain protein that is regulated by a mitogen-activated kinase is a substarte for c-Jun N-terminal kinase in the human central nervous system. Proc. Natl. Acad. Sci. USA. 95:1998;2586-2591.
144. Zhang P., Hogan E.L., Bhat N.R. Activation of JNK/SAPK in primary glial cultures: II. Differential activation of kinase isoforms corresponds to their differential expression. Neurochem. Res. 23:1998;219-225.
145. Zinck R., Cahill M.A., Kracht M., Sachsenmaier C., Hipskind R.A., Nordheim A. Protein-synthesis inhibitors reveal differential regulation of mitogen activated protein kinase pathways that converge on Elk-1. Mol. Cell. Biol. 15:1995;4930-4938.